Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.
Quinacrine is one of the few molecules tested to treat patients affected by prion diseases, although the clinical outcome is largely unsatisfactory. To identify novel derivatives with higher neuroprotective activity, we evaluated the effects of a small library of acridine derivatives. The 6-chloro-2-methoxyacridine derivatives bearing on position 9 a quinolizidin-1-ylamino (Q1, Q2) or a quinolizidin-1-ylalkylamino residue (Q3, Q4, Q6, Q7), the thio-bioisoster of Q3 (Q5), the 9-(N-lupinylthiopropyl)amino derivative (Q8) and simple acridines (Q9 and Q10) were considered. We compared the effects of quinacrine and these novel analogues in the inhibition of the cytotoxic activity and protease K (PK) resistance of the human prion protein fragment 90-231 (hPrP90-231). We demonstrate that quinacrine caused a significant reduction of hPrP90-231 toxicity due to its binding to the fragment and the prevention of its conversion in a toxic isoform. All acridine derivatives analyzed showed high affinity binding for hPrP90-231, but only Q3 and Q10, caused a significant reduction of hPrP90-231 cytotoxicity, with higher efficacy than quinacrine. We attempted to correlate the cytoprotective effects of the new compounds with some biochemical parameters (binding affinity to hPrP90-231, intrinsic fluorescence quenching, hydrophobic amino acid exposure), but a direct relationship occurred only with the reduction of PK resistance, likely due to the prevention of the acquisition of the β-sheet-rich toxic conformation. These data represent interesting leads for further modifications of the basic side chain and the substituent pattern of the acridine nucleus to develop novel compounds with improved antiprion activity to be tested in in vivo experimental setting.
Villa
Valentina
V
Laboratory of Pharmacology and Neuroscience, Department of Oncology, Biology and Genetics, University of Genova, Viale Benedetto XV, 2, 16132 Genoa, Italy.
Tonelli
Michele
M
Thellung
Stefano
S
Corsaro
Alessandro
A
Tasso
Bruno
B
Novelli
Federica
F
Canu
Caterina
C
Pino
Albiana
A
Chiovitti
Katia
K
Paludi
Domenico
D
Russo
Claudio
C
Sparatore
Anna
A
Aceto
Antonio
A
Boido
Vito
V
Sparatore
Fabio
F
Florio
Tullio
T
D000166:Acridines / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D002531:Cerebellum / Q000187:drug effects / Q000473:pathology; D006801:Humans; D010446:Peptide Fragments / Q000037:antagonists & inhibitors* / Q000633:toxicity*; D011328:Prions / Q000037:antagonists & inhibitors* / Q000633:toxicity*; D011796:Quinacrine / Q000031:analogs & derivatives / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016896:Treatment Outcome
D000166:Acridines; D010446:Peptide Fragments; D011328:Prions; C514520:prion protein (91-231), human; D011796:Quinacrine
Lancet Neurol. 2009 Apr;8(4):334-44
19278902
Dement Geriatr Cogn Disord. 2004;17(3):158-63
14739538
J Neurochem. 2003 Apr;85(1):62-72
12641727
J Neurochem. 2007 Dec;103(6):2291-300
17919292
Bioorg Med Chem. 2006 Jan 15;14(2):334-43
16216519
J Biol Chem. 1998 Feb 6;273(6):3484-9
9452472
Neurology. 2008 Apr 8;70(15):1272-81
18391159
J Med Chem. 1985 Dec;28(12):1843-7
4068007
J Biol Chem. 2001 Nov 23;276(47):43516-23
11533027
J Mol Biol. 2000 Jul 28;300(5):1309-22
10903871
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9836-41
11504948
Science. 2000 Feb 25;287(5457):1503-6
10688802
J Neurosci Res. 1999 Nov 1;58(3):426-35
10518116
Drug Metab Dispos. 2006 Jul;34(7):1136-44
16581945
PLoS Pathog. 2007 Aug 31;3(8):e125
17784787
N Engl J Med. 2001 May 17;344(20):1516-26
11357156
Arch Neurol. 2006 Apr;63(4):497-501
16606761
Ann Neurol. 2002 Oct;52(4):503-6
12325081
PLoS One. 2008 Mar 26;3(3):e1888
18365024
EMBO J. 2003 Oct 15;22(20):5435-45
14532116
J Neurochem. 2007 Dec;103(6):2597-609
17944873
Cell. 2004 Jan 23;116(2):313-27
14744440
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
9811807
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10849-54
12149459
J Neurochem. 1996 May;66(5):1995-2003
8780028
Semin Arthritis Rheum. 1989 May;18(4):282-96
2658071
Bioorg Med Chem. 2005 Sep 15;13(18):5338-45
16054368
J Virol. 2004 May;78(10):4999-5006
15113880
Farmaco Sci. 1987 Mar;42(3):159-74
3653383
Neurotoxicology. 2009 Jan;30(1):127-35
19056420
J Virol. 2000 May;74(10):4894-7
10775631
Lancet Neurol. 2009 Apr;8(4):304-6
19278901
J Med Chem. 2002 Oct 10;45(21):4689-94
12361395
Annu Rev Med. 2005;56:321-44
15660515
Clin Neuropharmacol. 2004 Jul-Aug;27(4):201-3
15319710
Farmaco. 1993 Aug;48(8):1021-49
8216667
Glia. 2007 Nov 1;55(14):1469-85
17705195
J Med Chem. 1999 Dec 30;42(26):5448-54
10639286
Lab Invest. 2003 Jun;83(6):837-43
12808118
Neurochem Int. 2002 Jul;41(1):55-63
11918972
Neurotox Res. 2009 Feb;15(2):138-54
19384577
J Neurochem. 1992 Aug;59(2):768-71
1352803
J Infect. 2005 Jun;50(5):394-6
15907546
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3416-21
12626750
Eur J Biochem. 2001 Mar;268(5):1352-62
11231287
J Med Chem. 2003 Aug 14;46(17):3563-4
12904059
Boll Chim Farm. 1989 Jun;128(6):212-5
2619989
PLoS Pathog. 2009 Nov;5(11):e1000673
19956709
Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):339-56
16831301
Ann N Y Acad Sci. 2006 Dec;1090:276-91
17384271
J Gen Virol. 2004 Aug;85(Pt 8):2479-2483
15269390
N Engl J Med. 1962 Aug 16;267:332-6
13912485
J Virol. 1995 Jan;69(1):506-8
7983747
Bioorg Med Chem Lett. 2006 Sep 15;16(18):4913-6
16860557
J Neurosci Res. 1998 Nov 1;54(3):341-52
9819139
Acc Chem Res. 2006 Sep;39(9):646-53
16981681
Bioorg Med Chem. 2008 Jul 15;16(14):6737-46
18556207
J Virol. 2006 Jan;80(2):1044-6
16379006
Rinsho Shinkeigaku. 2003 Jul;43(7):403-8
14582366
Arch Virol Suppl. 2000;(16):265-73
11214930
Trends Biochem Sci. 2001 Apr;26(4):235-42
11295556
J Virol. 2003 Aug;77(15):8462-9
12857915
Br J Pharmacol. 2005 Feb;144(3):386-93
15655516
Neurobiol Dis. 2002 Feb;9(1):69-81
11848686
Ann N Y Acad Sci. 2003 Dec;1010:610-22
15033801
BMC Infect Dis. 2004 Nov 29;4:53
15569390
Neurology. 2004 Mar 9;62(5):714-8
15007119
Clin Lab Med. 2003 Mar;23(1):187-208
12733432
Cell Mol Neurobiol. 2004 Apr;24(2):205-17
15176436
Science. 1991 Jun 14;252(5012):1515-22
1675487
J Med Chem. 2006 Nov 2;49(22):6591-5
17064077
Brain. 2006 Sep;129(Pt 9):2241-65
16816391